Medacta Group Statistics
Total Valuation
Medacta Group has a market cap or net worth of CHF 2.24 billion. The enterprise value is 2.45 billion.
Market Cap | 2.24B |
Enterprise Value | 2.45B |
Important Dates
The last earnings date was Thursday, October 31, 2024.
Earnings Date | Oct 31, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Medacta Group has 19.95 million shares outstanding. The number of shares has decreased by -0.13% in one year.
Current Share Class | n/a |
Shares Outstanding | 19.95M |
Shares Change (YoY) | -0.13% |
Shares Change (QoQ) | -0.24% |
Owned by Insiders (%) | 69.79% |
Owned by Institutions (%) | 16.68% |
Float | 6.03M |
Valuation Ratios
The trailing PE ratio is 41.56 and the forward PE ratio is 30.82.
PE Ratio | 41.56 |
Forward PE | 30.82 |
PS Ratio | 4.28 |
PB Ratio | 6.77 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.27, with an EV/FCF ratio of -1,461.84.
EV / Earnings | 45.25 |
EV / Sales | 4.67 |
EV / EBITDA | 19.27 |
EV / EBIT | 32.49 |
EV / FCF | -1,461.84 |
Financial Position
The company has a current ratio of 2.20, with a Debt / Equity ratio of 0.67.
Current Ratio | 2.20 |
Quick Ratio | 0.73 |
Debt / Equity | 0.67 |
Debt / EBITDA | 1.75 |
Debt / FCF | -132.68 |
Interest Coverage | 13.20 |
Financial Efficiency
Return on equity (ROE) is 17.52% and return on invested capital (ROIC) is 9.15%.
Return on Equity (ROE) | 17.52% |
Return on Assets (ROA) | 7.11% |
Return on Capital (ROIC) | 9.15% |
Revenue Per Employee | 286,993 |
Profits Per Employee | 29,639 |
Employee Count | 1,730 |
Asset Turnover | 0.79 |
Inventory Turnover | 0.85 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -4.97% in the last 52 weeks. The beta is 1.14, so Medacta Group's price volatility has been higher than the market average.
Beta (5Y) | 1.14 |
52-Week Price Change | -4.97% |
50-Day Moving Average | 118.56 |
200-Day Moving Average | 122.15 |
Relative Strength Index (RSI) | 42.92 |
Average Volume (20 Days) | 9,448 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medacta Group had revenue of CHF 524.05 million and earned 54.12 million in profits. Earnings per share was 2.70.
Revenue | 524.05M |
Gross Profit | 355.97M |
Operating Income | 75.38M |
Pretax Income | 64.69M |
Net Income | 54.12M |
EBITDA | 120.62M |
EBIT | 75.38M |
Earnings Per Share (EPS) | 2.70 |
Balance Sheet
The company has 15.80 million in cash and 222.27 million in debt, giving a net cash position of -206.47 million or -10.35 per share.
Cash & Cash Equivalents | 15.80M |
Total Debt | 222.27M |
Net Cash | -206.47M |
Net Cash Per Share | -10.35 |
Equity (Book Value) | 331.36M |
Book Value Per Share | 16.61 |
Working Capital | 191.15M |
Cash Flow
In the last 12 months, operating cash flow was 76.55 million and capital expenditures -78.22 million, giving a free cash flow of -1.68 million.
Operating Cash Flow | 76.55M |
Capital Expenditures | -78.22M |
Free Cash Flow | -1.68M |
FCF Per Share | -0.08 |
Margins
Gross margin is 67.93%, with operating and profit margins of 14.38% and 10.33%.
Gross Margin | 67.93% |
Operating Margin | 14.38% |
Pretax Margin | 12.34% |
Profit Margin | 10.33% |
EBITDA Margin | 23.02% |
EBIT Margin | 14.38% |
FCF Margin | -0.32% |
Dividends & Yields
This stock pays an annual dividend of 0.55, which amounts to a dividend yield of 0.49%.
Dividend Per Share | 0.55 |
Dividend Yield | 0.49% |
Dividend Growth (YoY) | 1.85% |
Years of Dividend Growth | 2 |
Payout Ratio | 20.78% |
Buyback Yield | 0.13% |
Shareholder Yield | 0.62% |
Earnings Yield | n/a |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Medacta Group has an Altman Z-Score of 5.92.
Altman Z-Score | 5.92 |
Piotroski F-Score | n/a |